Litcius/Paper detail

Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy

Mingzhu Chen, Ping Wang, Dazhen Jiang, Zhirong Bao, Hong Quan

2021Frontiers in Oncology18 citationsDOIOpen Access PDF

Abstract

Continuous high doses of radiation can cause irreversible side effects and radiation resistance; thus, advanced radiosensitizers are urgently needed. To overcome this problem, we developed a nano platelet radiosensitization system (PCA) by coating the chemotherapeutic drug cisplatin (CDDP) loaded gold nanocages (AuNs) within the platelet membrane. The developed PCA system may enable AuNs to have immune escape and targeting capabilities. After administration, PCA will actively target tumor cells and avoid being cleared by the immune system. Subsequently, CDDP, which destroys tumor cell DNA, can not only kill tumor cells directly but also combine with AuNs, which deposit radiation energy into tumor tissues, reducing RT resistance. In vivo and in vitro studies revealed that the combination of PCA with RT (2Gy) efficiently inhibits tumor proliferation without causing side effects such as inflammation. To conclude, this is the first attempt to use platelet membranes to correctly transport AuNs while also accomplishing low-dose RT, which could help AuNs-based tumor RT become more effective.

Topics & Concepts

NanocagesCancer researchPlateletIn vivoImmune systemCisplatinDrug deliveryDrugPharmacologyRadiation therapyBiodistributionIn vitroChemistryMedicineChemotherapyImmunologyBiologyInternal medicineBiochemistryBiotechnologyCatalysisOrganic chemistryNanoplatforms for cancer theranosticsExtracellular vesicles in diseaseNanoparticle-Based Drug Delivery
Platelet Membranes Coated Gold Nanocages for Tumor Targeted Drug Delivery and Amplificated Low-Dose Radiotherapy | Litcius